SYNERKINE PHARMA
Synerkine Pharma focuses on developing novel fusion proteins for the treatment of inflammatory, neuropathic and osteoarthritic pain. The company's protein targets common regulatory mechanisms in different types of chronic pain and has unique properties, enabling patients to effectively reduce pain in multiple pre-clinical models.
SYNERKINE PHARMA
Social Links:
Industry:
Biotechnology Health Care
Founded:
2009-01-01
Address:
Utrecht, Utrecht, The Netherlands
Country:
The Netherlands
Website Url:
http://www.synerkinepharma.com
Total Employee:
1+
Status:
Active
Total Funding:
12.1 M EUR
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Content Delivery Network Organization Schema Typekit Squarespace Squarespace Add To Cart
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Brighter
Data-driven solutions for smarter treatment of chronic conditions.
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
Neurocentrx
Neurocentrx Pharma Ltd. is a drug development company making products to treat chronic cancer pain.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
InnovationQuarter
InnovationQuarter investment in Series A - Synerkine Pharma
Utrecht Health Seed Fund
Utrecht Health Seed Fund investment in Series A - Synerkine Pharma
Netherlands Enterprise Agency
Netherlands Enterprise Agency investment in Debt Financing - Synerkine Pharma
Flerie Invest
Flerie Invest investment in Series A - Synerkine Pharma
Thuja Capital
Thuja Capital investment in Series A - Synerkine Pharma
Utrecht Holdings
Utrecht Holdings investment in Series A - Synerkine Pharma
Thuja Capital
Thuja Capital investment in Series A - Synerkine Pharma
Flerie Invest
Flerie Invest investment in Series A - Synerkine Pharma
Thuja Capital
Thuja Capital investment in Series A - Synerkine Pharma
Official Site Inspections
http://www.synerkinepharma.com
- Host name: 198.49.23.144
- IP address: 198.49.23.144
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Synerkine Pharma"
About Synerkine Pharma. Our team and the investors. — …
Synerkine Pharma is a Dutch biopharmaceutical company developing a novel class of biologics, called Synerkines, which connect different cytokines and enhance their activity through a …See details»
Synerkine Pharma - Crunchbase Company Profile & Funding
Synerkine Pharma focuses on developing novel fusion proteins for the treatment of inflammatory, neuropathic and osteoarthritic pain. The company's protein targets common regulatory …See details»
Synerkine Pharma - LinkedIn
Synerkine Pharma B.V. focuses on development of novel fusion proteins, called Synerkines, that combine the immunoregulatory activity of different cytokines.See details»
Synerkine Pharma. Investors — Synerkine Pharma
Utrecht Health Seed Fund (UHSF) is an early-stage life sciences & health investment fund based out of Utrecht, The Netherlands, focused on scalable technologies in the field of Life Sciences (therapeutics and diagnostics), …See details»
Synerkine Pharma Company Profile | Management and Employees …
Www.synerkinepharma.com Synerkine Pharma Profile and History Synerkine Pharma is a preclinical stage biotech company, developing a new class of powerful cytokine fusion proteins …See details»
Synerkine Pharma - Overview, News & Similar companies
Who is Synerkine Pharma. Synerkine Pharma is a preclinical stage biotech company, developing a new class of powerful cytokine fusion proteins aimed to treat disorders such as chronic pain, …See details»
Synerkine Pharma BV - Drug pipelines, Patents, Clinical trials
Nov 14, 2024 www.synerkinepharma.com. Holding Company | 2009 | Netherlands | < 10 | www.synerkinepharma.com. Last update 01 Nov 2024. Overview. Pipeline. Deal. Translational …See details»
Synerkine Pharma - Products, Competitors, Financials, Employees ...
For more information about Synerkine, we refer you to the company website: synerkinepharma.com . Please find full press release here: press release . Oct 15, 2023. …See details»
Synerkine Pharma’s Competitors, Revenue, Number of Employees …
Synerkine Pharma’s Profile, Revenue and Employees. Synerkine is a Netherlands-based biopharmaceutical company that discovers and develops novel fusion proteins for the …See details»
Synerkine Pharma - Craft
Synerkine Pharma has 1 employees across 2 locations. See insights on Synerkine Pharma including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
Manufacturing Alliance with NorthX Biologics — Synerkine Pharma
Feb 19, 2024 Synerkine Pharma and NorthX Biologics sign manufacturing alliance. Leiden, The Netherlands - February 19, 2024 - Synerkine Pharma, a Dutch biopharmaceutical company …See details»
Synerkine Pharma secures €12.1 million to accelerate novel pain ...
Oct 12, 2023 Flerie leads Series A extension with other existing investor Thuja Capital participating and new investors InnovationQuarter Capital and Utrecht Health Seed Fund …See details»
Synerkine Pharma - Company Profile - Tracxn
Dec 17, 2021 Synerkine Pharma ranks 22nd among 84 active competitors. 24 of its competitors are funded while 12 have exited. Overall, Synerkine Pharma and its competitors have raised …See details»
Synerkine Pharma - PitchBook
Synerkine Pharma General Information Description. Developer of fusion proteins designed to help in the treatment of inflammatory and neuropathic pain. The company's protein targets common …See details»
Synerkine Pharma Company Information - Funding, Investors, and …
Https://synerkinepharma.com. Developer of fusion proteins for treating chronic pain. GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY. OR DOWNLOAD …See details»
Technology of Synerkine Pharma — Synerkine Pharma
SYNERKINES, HARNESSING THE POWER OF RECEPTOR CLUSTERING. Synerkines retain the ability to activate the individual cytokine receptors by heterodimerizing the receptor chainsSee details»
Synerkine Pharma raises EUR 3.5 million in an extended Series A ...
Dec 17, 2021 Naarden, The Netherlands, December 16, 2021 -- Synerkine Pharma B.V. announced today that it has added EUR 3.5 million to its Series A funding. The extension was …See details»
Synerkine Pharma. Pipeline — Synerkine Pharma
Chronic pain. Acute pain is typically induced by a noxious stimulus or tissue damage and normally resolves by itself. If pain persists more than 3 months, despite the initial stimulus or tissue …See details»
News — Synerkine Pharma
Synerkine Pharma today announced a manufacturing alliance with NorthX Biologics AB, a leading biopharmaceutical company committed to pioneering solutions in gene therapy and …See details»